Literature DB >> 22650256

Small-molecule inhibitors of protein-protein interactions: how to mimic a protein partner.

David C Fry1.   

Abstract

This systematic review describes successful examples of small-molecule inhibitors of protein-protein interactions, and compares their binding strategies to those employed by the natural protein partners. It extends and updates an earlier survey of this type (Fry DC, Curr Prot Pep Sci 2008; 9: 240-7). From analysis of these systems, common themes and lessons are presented that may assist future drug discovery efforts involving targets in this class. One encouraging finding is that a wide scope appears to be allowed at these sites in terms of binding strategies and chemotypes, which suggests that the outlook for finding small-molecule protein-protein inhibitors is favorable.

Mesh:

Substances:

Year:  2012        PMID: 22650256     DOI: 10.2174/138161212802651634

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  17 in total

1.  2P2I HUNTER: a tool for filtering orthosteric protein-protein interaction modulators via a dedicated support vector machine.

Authors:  Véronique Hamon; Raphael Bourgeas; Pierre Ducrot; Isabelle Theret; Laura Xuereb; Marie Jeanne Basse; Jean Michel Brunel; Sebastien Combes; Xavier Morelli; Philippe Roche
Journal:  J R Soc Interface       Date:  2013-11-06       Impact factor: 4.118

2.  Combining in silico and in cerebro approaches for virtual screening and pose prediction in SAMPL4.

Authors:  Arnout R D Voet; Ashutosh Kumar; Francois Berenger; Kam Y J Zhang
Journal:  J Comput Aided Mol Des       Date:  2014-01-21       Impact factor: 3.686

Review 3.  Small-molecule inhibitors of protein-protein interactions: progressing toward the reality.

Authors:  Michelle R Arkin; Yinyan Tang; James A Wells
Journal:  Chem Biol       Date:  2014-09-18

Review 4.  HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Authors:  Guangdi Li; Erik De Clercq
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-29       Impact factor: 11.056

5.  Why Some Targets Benefit from beyond Rule of Five Drugs.

Authors:  Megan Egbert; Adrian Whitty; György M Keserű; Sandor Vajda
Journal:  J Med Chem       Date:  2019-06-26       Impact factor: 7.446

6.  Strategies for lead discovery: application of footprint similarity targeting HIVgp41.

Authors:  Patrick M Holden; William J Allen; Miriam Gochin; Robert C Rizzo
Journal:  Bioorg Med Chem       Date:  2013-10-26       Impact factor: 3.641

7.  Improved assays for determining the cytosolic access of peptides, proteins, and their mimetics.

Authors:  Justin M Holub; Jonathan R Larochelle; Jacob S Appelbaum; Alanna Schepartz
Journal:  Biochemistry       Date:  2013-11-20       Impact factor: 3.162

8.  Mitigating cold-start problems in drug-target affinity prediction with interaction knowledge transferring.

Authors:  Tri Minh Nguyen; Thin Nguyen; Truyen Tran
Journal:  Brief Bioinform       Date:  2022-07-18       Impact factor: 13.994

Review 9.  Targeting human papillomavirus genome replication for antiviral drug discovery.

Authors:  Jacques Archambault; Thomas Melendy
Journal:  Antivir Ther       Date:  2013-04-24

Review 10.  On the binding affinity of macromolecular interactions: daring to ask why proteins interact.

Authors:  Panagiotis L Kastritis; Alexandre M J J Bonvin
Journal:  J R Soc Interface       Date:  2012-12-12       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.